<DOC>
	<DOCNO>NCT00150007</DOCNO>
	<brief_summary>The purpose study assess impact GI complaints patient report outcomes renal transplant recipient determine improvement patient report outcomes patient convert EC-MPS-based immunosuppressive treatment .</brief_summary>
	<brief_title>Measurement Patient Reported Outcomes Renal Transplant Patients With Without Gastrointestinal ( GI ) Symptoms ( PROGIS )</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Received kidney transplant least 1 month prior study enrollment ; Receiving immunosuppressive regimen include MMF least 2 week prior study enrollment ; Eligible convert ECMPS GI complaint OR currently experience GI complaint stable current immunosuppressive regimen ; At least 18 year age ; Willing provide write informed consent ; Able meet study requirement include complete paper questionnaire complete two study visit . GI symptom assume know caused MPA therapy ( e.g . oral biphosphonates induce , infectious diarrhea ) ; Acute rejection &lt; 1 week prior study enrollment ; Woman childbearing potential planning become pregnant pregnant and/or lactate unwilling use effective mean contraception ; Presence psychiatric illness ( i.e. , schizophrenia , major depression ) , opinion site investigator , would interfere study requirement ; Undergoing acute medical intervention hospitalization ; Any medical condition , opinion site investigator base recall chart review , would interfere complete study , include limited , visual problem cognitive impairment Receiving investigational drug receive investigational drug within 30 day prior study enrollment . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Kidney , maintenance transplant , GI complaint , patient report outcome</keyword>
</DOC>